Allmed Medical Products Co Ltd Class A
Allmed Medical Products Co., Ltd manufactures and sells wound care and nursing material products in China. The company's traditional wound care products include non-woven and woven gauze swabs, non-adherent pads, drain sponges, abdominal pads, fluffy sponges/bandages, woven gauze and nonwoven gauze balls, eye pads, cotton-filled exodontia sponges, packing strips, ribbon gauze, cotton-tipped appli… Read more
Allmed Medical Products Co Ltd Class A (002950) - Total Assets
Latest total assets as of September 2025: CN¥5.35 Billion CNY
Based on the latest financial reports, Allmed Medical Products Co Ltd Class A (002950) holds total assets worth CN¥5.35 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Allmed Medical Products Co Ltd Class A - Total Assets Trend (2014–2024)
This chart illustrates how Allmed Medical Products Co Ltd Class A’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Allmed Medical Products Co Ltd Class A - Asset Composition Analysis
Current Asset Composition (December 2024)
Allmed Medical Products Co Ltd Class A's total assets of CN¥5.35 Billion consist of 38.1% current assets and 61.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 11.6% |
| Accounts Receivable | CN¥524.93 Million | 10.4% |
| Inventory | CN¥615.27 Million | 12.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥182.78 Million | 3.6% |
| Goodwill | CN¥95.30 Million | 1.9% |
Asset Composition Trend (2014–2024)
This chart illustrates how Allmed Medical Products Co Ltd Class A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Allmed Medical Products Co Ltd Class A's current assets represent 38.1% of total assets in 2024, a decrease from 50.3% in 2014.
- Cash Position: Cash and equivalents constituted 11.6% of total assets in 2024, down from 13.7% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, unchanged from 4.0% in 2014.
- Asset Diversification: The largest asset category is inventory at 12.2% of total assets.
Allmed Medical Products Co Ltd Class A Competitors by Total Assets
Key competitors of Allmed Medical Products Co Ltd Class A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
Allmed Medical Products Co Ltd Class A - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Allmed Medical Products Co Ltd Class A generates 0.66x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Allmed Medical Products Co Ltd Class A generates $7.29 in net profit.
Allmed Medical Products Co Ltd Class A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.00 | 1.58 | 1.94 |
| Quick Ratio | 1.35 | 1.06 | 1.45 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.10 Billion | CN¥ 728.29 Million | CN¥ 1.37 Billion |
Allmed Medical Products Co Ltd Class A - Advanced Valuation Insights
This section examines the relationship between Allmed Medical Products Co Ltd Class A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.86 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | -0.5% |
| Total Assets | CN¥5.06 Billion |
| Market Capitalization | $346.13 Million USD |
Valuation Analysis
Below Book Valuation: The market values Allmed Medical Products Co Ltd Class A's assets below their book value (0.07 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Allmed Medical Products Co Ltd Class A's assets decreased by 0.5% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Allmed Medical Products Co Ltd Class A (2014–2024)
The table below shows the annual total assets of Allmed Medical Products Co Ltd Class A from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥5.06 Billion | -0.50% |
| 2023-12-31 | CN¥5.08 Billion | -11.54% |
| 2022-12-31 | CN¥5.75 Billion | +14.84% |
| 2021-12-31 | CN¥5.00 Billion | +3.06% |
| 2020-12-31 | CN¥4.86 Billion | +53.88% |
| 2019-12-31 | CN¥3.16 Billion | +8.81% |
| 2018-12-31 | CN¥2.90 Billion | +27.62% |
| 2017-12-31 | CN¥2.27 Billion | +19.77% |
| 2016-12-31 | CN¥1.90 Billion | +2.67% |
| 2015-12-31 | CN¥1.85 Billion | +5.56% |
| 2014-12-31 | CN¥1.75 Billion | -- |